ATE496632T1 - Synthetischer impfstoff zur zeckeneindämmung - Google Patents

Synthetischer impfstoff zur zeckeneindämmung

Info

Publication number
ATE496632T1
ATE496632T1 AT01927509T AT01927509T ATE496632T1 AT E496632 T1 ATE496632 T1 AT E496632T1 AT 01927509 T AT01927509 T AT 01927509T AT 01927509 T AT01927509 T AT 01927509T AT E496632 T1 ATE496632 T1 AT E496632T1
Authority
AT
Austria
Prior art keywords
synthetic
bovines
inoculated
construction
terminal
Prior art date
Application number
AT01927509T
Other languages
English (en)
Inventor
Salcedo Joaquim Patarroyo
Viloria Marlene Vargas
Prates Aline Alencar
Mendes Marcio Dias
Fanny Guzman
Portela Ricardo Dias
Castro Oliveira Ricardo De
Murillo Manuel Patarroyo
Original Assignee
Univ Fed Vicosa
Fundacaeo De Amparo Pesquisa Do Estado De Minas Gerais
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Fed Vicosa, Fundacaeo De Amparo Pesquisa Do Estado De Minas Gerais filed Critical Univ Fed Vicosa
Application granted granted Critical
Publication of ATE496632T1 publication Critical patent/ATE496632T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT01927509T 2000-05-04 2001-05-04 Synthetischer impfstoff zur zeckeneindämmung ATE496632T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI0001717-5B1A BR0001717B1 (pt) 2000-05-04 2000-05-04 Vacina sintética para o controle de carrapatos
PCT/BR2001/000057 WO2001082957A1 (en) 2000-05-04 2001-05-04 Snthetic vaccine for tick control

Publications (1)

Publication Number Publication Date
ATE496632T1 true ATE496632T1 (de) 2011-02-15

Family

ID=3944119

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01927509T ATE496632T1 (de) 2000-05-04 2001-05-04 Synthetischer impfstoff zur zeckeneindämmung

Country Status (10)

Country Link
US (2) US20040052807A1 (de)
EP (1) EP1289545B1 (de)
AT (1) ATE496632T1 (de)
AU (1) AU779537B2 (de)
BR (1) BR0001717B1 (de)
DE (1) DE60143940D1 (de)
ES (1) ES2360430T3 (de)
MX (1) MXPA02010851A (de)
PT (1) PT1289545E (de)
WO (1) WO2001082957A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2422215A (en) * 2005-01-14 2006-07-19 Sendo Int Ltd Customizing a software based product using embedded software elements
ES2352946B1 (es) * 2008-04-16 2012-01-23 CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (Titular al 50%) Sistema para la expresión de péptidos sobre la superficie bacteriana.
US8722063B2 (en) 2012-05-24 2014-05-13 The United States Of America, As Represented By The Secretary Of Agriculture Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission
BR112015023054B1 (pt) 2013-03-13 2023-02-23 Board Of Supervisors, Louisiana State University And A&M College Vacinação de animais de companhia para induzir uma resposta imunológica protetora contra infestações por carrapatos e a transmissão de agentes patogênicos por carrapatos
BR102013026625B1 (pt) 2013-10-16 2022-04-26 Universidade Federal de Viçosa Vacina de peptídeos recombinantes para o controle de carrapatos e sequências de nucleotídeos codificadoras dos peptídeos recombinantes
CN104007215B (zh) * 2014-05-07 2015-08-26 广东药学院 中药罗仙子指纹图谱的构建方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US869657A (en) 1907-05-21 1907-10-29 J W Flanagan Clam-shell bucket.
US6235283B1 (en) * 1986-11-27 2001-05-22 Biotechnology Australia Pty. Ltd. DNA encoding a cell membrane glycoprotein of a tick gut
ZA932352B (en) 1993-04-01 1994-06-10 Centro De Ingeneria Genetica Y Procedure for the production of a tick particulated antigen in pichia pastoris yeast and the vaccinepreparation obtained
AU8091694A (en) * 1993-10-26 1995-05-22 United Biomedical Inc. Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics

Also Published As

Publication number Publication date
US8110202B2 (en) 2012-02-07
DE60143940D1 (de) 2011-03-10
PT1289545E (pt) 2011-05-03
BR0001717B1 (pt) 2013-10-08
AU779537B2 (en) 2005-01-27
AU5453801A (en) 2001-11-12
MXPA02010851A (es) 2004-05-20
WO2001082957A1 (en) 2001-11-08
US20050281836A1 (en) 2005-12-22
ES2360430T3 (es) 2011-06-03
EP1289545A1 (de) 2003-03-12
EP1289545B1 (de) 2011-01-26
US20040052807A1 (en) 2004-03-18
BR0001717A (pt) 2002-03-19

Similar Documents

Publication Publication Date Title
DK0759944T3 (da) Forbedringer af og relateret til peptidfremføring
DK1844150T3 (da) Rekombinant ekspression af proteiner i en to-kædet form med disulfidbroer
AR003087A1 (es) PROTEINAS OBESAS RECOMBINANTES (Oh), VECTOR DE EXPRESION, PROTEINA DE FUSION, SECUENCIA DE ADN, METODO PARA PRODUCIR DICHAS PROTEINAS, COMPOSICIONQUE LAS COMPRENDE, EMPLEO DE DICHAS PROTEINAS Y METODO DE TRATAMIENTO.
ATE388963T1 (de) Homogene herstellungen von il-29
BRPI0412799A (pt) imunógeno, composição, ácido nucleico, célula recombinante, métodos para preparar um polipeptìdeo, para induzir um a resposta imune protetora em um paciente e para induzir uma resposta anamnésica em um paciente, e, seqüência de ácido nucleico otimizada de levedura
DE69922958D1 (de) Hcv hüllproteine partikel : verwendung für therapeutische impfung
BR0312537A (pt) Usos de hidrolisato de proteìna de soro em composição comestìvel, método de indução da saciedade em seres humanos ou animais e método de melhoria ou controle da percepção da imagem do corpo e/ou controle do peso do corpo e/ou controle da ingestão de calorias e/ou auxìlio na adesão a um plano de dieta
DE60035419D1 (de) Antigene peptide aus neisseria
MX9200709A (es) Activacion mejorada de proteinas recombinadas. activacion mejorada de proteinas recombinadas.
ATE278708T1 (de) Conotoxin peptid pviia
MX2021014497A (es) Peptidos.
DE60335726D1 (de) Chromoprotein und fluoroproteine
ATE496632T1 (de) Synthetischer impfstoff zur zeckeneindämmung
DK0491628T3 (da) Lipopeptider inducerende cytotoksiske T-lymfocytter og deres anvendelse som vacciner
MXPA03005218A (es) Peptidos y/o proteinas y uso de los mismos para la produccion de un medicamento terapeutico y/o profilactico.
ATE205219T1 (de) Ein verbessertes peptid, immunogene zusammensetzung und impfstoff oder medizinische präparate, eine methode zur immunisierung von tieren gegen das hormon lhrh und analoge des lhrh-tendem-repeat-peptid und deren verwendung als impfstoff
BR112022020438A2 (pt) Composições compreendendo três proteínas de fusão ospa para uso médico
TW200504216A (en) Immunization of fish with plant-expressed recombinant proteins
WO2004022092A3 (en) Flagellin peptides as adjuvants for vaccines
RU95107705A (ru) Полипептид, рекомбинантный полинуклеотид, вакцина, применение вакцины
BR0110791A (pt) Composição, métodos para induzir uma resposta imune em um indivìduo contra um imunogene, para modular o sistema imune de um indivìduo e para imunizar um indivìduo contra um patógeno, vacina recombinante, e patógeno atenuado vivo
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
DE60223232D1 (de) Mucinpeptid mit immunstärkenden eigenschaften
DE60138885D1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
BR9903530A (pt) Protease aspártica ou peptìdeos derivados utilizados para imunização contra o carrapato

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties